Search Results 131-140 of 18714 for amyloidosis

  1. A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving ABBV-383 as an Intravenous (IV) Infusion - Mayo Clinic

    A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving ABBV-383 ...

  2. In the Loop: Second opinion provides a double-take and points to hope - Mayo Clinic News Network

    When Mackenzie Boedicker was diagnosed with amyloidosis, she knew nothing about the disease. That's changed, and she's using her new knowledge to raise ...

  3. TRITON-CM: A Study To Evaluate Nucresiran In Patients With Transthyretin Amyloidosis With Cardiomyopathy - Mayo Clinic

    TRITON-CM: A Study To Evaluate Nucresiran In Patients With Transthyretin Amyloidosis With Cardiomyopathy · Overview · Participation eligibility · Participating ...

  4. Awais A. Malik, M.D. - Doctors and Medical Staff - Mayo Clinic

    In addition to cardiac amyloidosis, Dr. Malik has a particular interest in the diagnosis and management of other infiltrative cardiomyopathies and ...

  5. Acoramidis Transthyretin Amyloidosis Prevention Trial In The Young (ACT-EARLY) Study In Asymptomatic Carriers Of A Pathogenic TTR Variant - Mayo Clinic

    About this study. Transthyretin amyloidosis (ATTR) is a disease where the normally occurring transthyretin (TTR) protein falls apart and forms amyloid, ...

  6. A Study to Evaluate the Prevalence of Transthyretin Cardiac Amyloidosis in Heart Failure Patients with Preserved Ejection Fraction in Southeastern Minnesota - Mayo Clinic

    A Study to Evaluate the Prevalence of Transthyretin Cardiac Amyloidosis in Heart Failure Patients with Preserved Ejection Fraction in Southeastern Minnesota.

  7. Domino liver transplant - Mayo Clinic

    You may develop symptoms of amyloidosis, but it usually takes decades to develop. Doctors select recipients 60 years old or older, who doctors don't expect will ...

  8. An Extension Study to Evaluate the Long-Term Safety and Tolerability of NEOD001 for Treatment of People with Light Chain Amyloidosis - Mayo Clinic

    An Extension Study to Evaluate the Long-Term Safety and Tolerability of NEOD001 for Treatment of People with Light Chain Amyloidosis ... amyloidosis who completed ...

  9. A research study to look at long-term treatment with a medicine called NNC6019-0001 for people who have heart failure due to transthyretin amyloidosis - Mayo Clinic

    A research study to look at long-term treatment with a medicine called NNC6019-0001 for people who have heart failure due to transthyretin amyloidosis · Overview.

  10. Rare treatment for rare disease: Triple transplant - Mayo Clinic News Network

    Watson has hereditary amyloidosis, a relatively rare blood disease that develops when protein builds up in organs and tissues. Affected areas can include the ...